Research On Business Performance Evaluation Of BYS Pharmaceutical Company Under High Quality Development

General Secretary Xi Jinping pointed out in his report to the 19 th National Congress that China’s economy has shifted from a stage of rapid growth to a stage of high-quality development.In the era of high quality economic development,the strategic business objectives of enterprises should be located in the pursuit of high quality business performance,in order to seek sustainable enterprise value maximization.As the dual risks of COVID-19 and influenza are superimposed,China’s epidemic prevention and control has entered a new stage,and the pharmaceutical industry,as an important part of the national economy,has received more attention.The business performance evaluation method under the background of high-quality economic development can make the pharmaceutical enterprises pay more attention to the problems behind the relevant indicators,and then promote the pharmaceutical industry to constantly move forward in the direction of high-quality development.This thesis taking BYS Pharmaceutical company as the research object,first introduces the research background and significance of establishing the business performance evaluation system under the background of high quality development for BYS Pharmaceutical company,and reviews the relevant literature at home and abroad.Secondly,the relevant theories and the reference basis of constructing the evaluation system are explained in detail,and the relevant theoretical basis is introduced.Then,this thesis introduces BYS Pharmaceutical company’s general situation of the enterprise and the shortcomings of the existing performance evaluation methods,and then expounds the necessity and feasibility of business performance evaluation based on high-quality development,and establishes a business performance evaluation system under the background of high-quality development.The establishment of the evaluation system is based on the five concept dimensions of high-quality development,namely innovation,green,coordination,openness and sharing,and value creation dimension from traditional financial perspective.The enterprise strategic objectives of BYS Pharmaceutical company are subdivided,and then corresponding performance evaluation indicators are designed according to each subdivision dimension.After that,entropy method is used to determine the weight of high-quality development indicators.And through the improved efficacy coefficient method to get the performance evaluation results of BYS pharmaceutical company,and then carried out objective and comprehensive analysis and evaluation under six dimensions.Finally,this thesis puts forward the corresponding safeguard measures for the sustainable and effective operation of the evaluation system.This thesis builds a business performance evaluation system for BYS Pharmaceutical company based on the historical background of high-quality development,which can make the business performance evaluation content of the enterprise more fully and effectively combine with the company’s development strategy.It not only has more far-reaching strategic significance for BYS Pharmaceutical to achieve high-quality development as soon as possible,In addition,the research can also provide reference for pharmaceutical enterprises to establish a high quality development direction of business performance evaluation system.